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  To	  the	  editor:	  	  Hall	  and	  Lucke	  (2010)	  pack	  many	  important	  points	  into	  their	  editorial	  on	  enhancement	  use	  of	  neuropharmaceuticals,	  and	  overall	  I	  agree	  with	  the	  authors	  that	  more	  skepticism	  and	  caution	  are	  needed	  in	  discussions	  of	  this	  topic.	  	  However,	  in	  attempting	  to	  counteract	  some	  of	  the	  exaggeration	  and	  hype	  that	  has	  beset	  this	  topic,	  I	  worry	  that	  the	  editorial	  encourages	  readers	  to	  dismiss	  the	  phenomenon	  as	  a	  minor	  issue	  for	  neuroethics	  and	  drug	  policy.	  	  The	  authors	  begin	  by	  raising	  the	  question	  “How	  common	  is	  ‘neuroenhancement’?”	  and	  correctly	  point	  out	  that	  good	  statistics	  are	  hard	  to	  come	  by.	  	  They	  conclude	  that	  the	  percentage	  prevalence	  among	  American	  undergraduates	  may	  be	  single-­‐digit	  and	  likely	  as	  low	  as	  3%.	  	  However,	  given	  that	  there	  are	  estimated	  to	  be	  18	  million	  college	  students	  in	  the	  US	  (NCES,	  2009),	  even	  the	  low	  3%	  figure	  implies	  that	  over	  a	  half	  million	  healthy	  young	  people	  are	  current	  or	  recent	  users	  in	  the	  US	  alone.	  	  Understanding	  the	  phenomenon	  of	  cognitive	  enhancement	  is	  therefore	  a	  significant	  public	  health	  priority.	  	  The	  authors	  next	  turn	  their	  skeptical	  focus	  to	  the	  question	  of	  “How	  enhancing	  are	  ‘neuroenhancers’?”	  A	  fresh	  look	  at	  this	  issue	  is	  indeed	  overdue,	  and	  I	  myself	  have	  recently	  concluded	  that	  the	  cognitive	  benefits	  of	  ADHD	  medications	  for	  normal	  individuals	  are	  probably	  smaller	  and	  less	  reliable	  than	  generally	  assumed	  in	  the	  neuroethics	  literature	  on	  cognitive	  enhancement	  (Smith	  &	  Farah,	  in	  press).	  This	  may	  be	  due	  in	  part	  to	  publication	  and	  citation	  biases	  against	  null	  results.	  	  Nevertheless,	  a	  small	  effect	  is	  not	  the	  same	  as	  no	  effect,	  and	  in	  many	  situations	  a	  small	  edge	  can	  be	  important.	  	  Furthermore,	  users	  report	  benefiting	  from	  the	  motivational	  effects	  of	  the	  medications	  (e.g.,	  DeSantis,	  Webb	  &	  Noar,	  2008).	  	  One	  could	  of	  course	  question	  the	  label	  ‘cognitive	  enhancement’	  if	  this	  is	  turns	  out	  to	  be	  the	  drugs’	  primary	  benefit.	  	  However,	  it	  is	  difficult	  to	  separate	  the	  question	  of	  what	  seems	  interesting	  (motivation)	  from	  what	  can	  be	  attended	  to	  (cognition).	  	  Hall	  and	  Lucke	  have	  challenged	  our	  field	  to	  look	  beyond	  the	  facile	  treatments	  of	  neurocognitive	  enhancement	  that	  can	  be	  found	  in	  the	  scholarly	  as	  well	  as	  popular	  press.	  	  For	  this	  I	  applaud	  them.	  	  However,	  I	  would	  also	  urge	  them	  to	  be	  a	  bit	  more	  cautious	  themselves	  when	  questioning	  the	  reality	  of	  neurocognitive	  enhancement	  and	  its	  prevalence.	  	  This	  practice	  involves	  large	  numbers	  of	  people,	  whose	  cognition	  and	  motivation	  are	  affected	  in	  as	  yet	  poorly	  characterized	  ways,	  and	  who	  are	  generally	  engaging	  in	  this	  practice	  without	  medical	  supervision.	  	  These	  are	  indisputable	  facts	  that	  call	  for	  more	  concern	  about	  the	  problem	  of	  cognitive	  enhancement,	  not	  less.	  	  Sincerely,	  	  Martha	  J.	  Farah	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